vTv Therapeutics (VTVT) Minority Interest (2016 - 2025)
Historic Minority Interest for vTv Therapeutics (VTVT) over the last 12 years, with Q2 2025 value amounting to -$357000.0.
- vTv Therapeutics' Minority Interest fell 10901.06% to -$357000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$357000.0, marking a year-over-year decrease of 10901.06%. This contributed to the annual value of $2.1 million for FY2024, which is 6571.52% down from last year.
- According to the latest figures from Q2 2025, vTv Therapeutics' Minority Interest is -$357000.0, which was down 10901.06% from $977000.0 recorded in Q1 2025.
- In the past 5 years, vTv Therapeutics' Minority Interest ranged from a high of $62.6 million in Q1 2021 and a low of -$357000.0 during Q2 2025
- In the last 5 years, vTv Therapeutics' Minority Interest had a median value of $15.1 million in 2022 and averaged $18.5 million.
- In the last 5 years, vTv Therapeutics' Minority Interest skyrocketed by 3642.37% in 2023 and then tumbled by 10901.06% in 2025.
- Quarter analysis of 5 years shows vTv Therapeutics' Minority Interest stood at $25.0 million in 2021, then crashed by 33.58% to $16.6 million in 2022, then crashed by 63.02% to $6.1 million in 2023, then plummeted by 65.72% to $2.1 million in 2024, then plummeted by 116.98% to -$357000.0 in 2025.
- Its last three reported values are -$357000.0 in Q2 2025, $977000.0 for Q1 2025, and $2.1 million during Q4 2024.